Literature DB >> 25922219

Quality Indicators of End-of-Life Care in Patients With Cancer: What Rate Is Right?

Lisa Barbera1, Hsien Seow2, Rinku Sutradhar2, Anna Chu2, Fred Burge2, Konrad Fassbender2, Kim McGrail2, Beverley Lawson2, Ying Liu2, Reka Pataky2, Alex Potapov2.   

Abstract

PURPOSE: To develop data-driven and achievable benchmark rates for end-of-life quality indicators using administrative data from four provinces in Canada.
METHODS: Indicators of end-of-life care were defined and measured using linked administrative data for 33 health regions across British Columbia, Alberta, Ontario, and Nova Scotia. These were emergency department use, intensive care unit admission, physician house calls and home care visits before death, and death in hospital. An empiric benchmark was defined using indicator rates from the top-ranked regions to include the top decile of patients overall. Funnel plots were used to graph each region's age- and sex-adjusted indicator rates along with the overall rate and 95% confidence limits.
RESULTS: Rates varied approximately two- to four-fold across the regions, with physician house calls showing the greatest variation. Benchmark rates based on the top decile performers were emergency department use, 34%; intensive care unit admission, 2%; physician house calls, 34%; home care visits, 63%; and death in hospital, 38%. With the exception of intensive care unit admission, funnel plots demonstrated that overall indicator rates and their confidence limits were uniformly worse than benchmarks even after adjusting for age and sex. Few regions met the benchmark rates.
CONCLUSION: There is significant variation in end-of-life quality indicators across regions in four provinces in Canada. Using this study's methods-deriving empiric benchmarks and funnel plots-regions can determine their relative performance with greater context that facilitates priority setting and resource deployment. Applying this study's methods can support quality improvement by decreasing variation and striving for a target.
Copyright © 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 25922219     DOI: 10.1200/JOP.2015.004416

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  16 in total

1.  Population-based trends in systemic therapy use and cost for cancer patients in the last year of life.

Authors:  R E Pataky; W Y Cheung; C de Oliveira; K E Bremner; K K W Chan; J S Hoch; M D Krahn; S J Peacock
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

Review 2.  Integrating palliative care in oncologic emergency departments: Challenges and opportunities.

Authors:  Ahmed F Elsayem; Hiba E Elzubeir; Patricia A Brock; Knox H Todd
Journal:  World J Clin Oncol       Date:  2016-04-10

3.  Impact of the Physician Orders for Life-Sustaining Treatment (POLST) Program Maturity Status on the Nursing Home Resident's Place of Death.

Authors:  Aluem Tark; Mansi Agarwal; Andrew W Dick; Jiyoun Song; Patricia W Stone
Journal:  Am J Hosp Palliat Care       Date:  2020-09-03       Impact factor: 2.500

4.  Comparing enrolees with non-enrolees of cancer-patient navigation at end of life.

Authors:  G Park; G M Johnston; R Urquhart; G Walsh; M McCallum
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

5.  A Stakeholder-Driven Qualitative Study to Define High Quality End-of-Life Care for Children With Cancer.

Authors:  Prasanna Ananth; Sophia Mun; Noora Reffat; Randall Li; Tannaz Sedghi; Madeline Avery; Jennifer Snaman; Cary P Gross; Xiaomei Ma; Joanne Wolfe
Journal:  J Pain Symptom Manage       Date:  2021-02-05       Impact factor: 5.576

6.  Associations between physician home visits for the dying and place of death: A population-based retrospective cohort study.

Authors:  Peter Tanuseputro; Sarah Beach; Mathieu Chalifoux; Walter P Wodchis; Amy T Hsu; Hsien Seow; Douglas G Manuel
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

7.  Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history.

Authors:  Rebecca Reeve; Preeyaporn Srasuebkul; Julia M Langton; Marion Haas; Rosalie Viney; Sallie-Anne Pearson
Journal:  BMC Palliat Care       Date:  2017-06-21       Impact factor: 3.234

Review 8.  Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review.

Authors:  Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton
Journal:  J Pain Symptom Manage       Date:  2019-10-19       Impact factor: 3.612

9.  Effectiveness of two types of palliative home care in cancer and non-cancer patients: A retrospective population-based study using claims data.

Authors:  Markus Krause; Bianka Ditscheid; Thomas Lehmann; Maximiliane Jansky; Ursula Marschall; Winfried Meißner; Friedemann Nauck; Ulrich Wedding; Antje Freytag
Journal:  Palliat Med       Date:  2021-06       Impact factor: 4.762

10.  Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective.

Authors:  Julia M Langton; Rebecca Reeve; Preeyaporn Srasuebkul; Marion Haas; Rosalie Viney; David Currow; Sallie-Anne Pearson
Journal:  Br J Cancer       Date:  2016-04-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.